Nature Communications (Nov 2023)

Contribution of pks + E. coli mutations to colorectal carcinogenesis

  • Bingjie Chen,
  • Daniele Ramazzotti,
  • Timon Heide,
  • Inmaculada Spiteri,
  • Javier Fernandez-Mateos,
  • Chela James,
  • Luca Magnani,
  • Trevor A. Graham,
  • Andrea Sottoriva

DOI
https://doi.org/10.1038/s41467-023-43329-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 9

Abstract

Read online

Abstract The dominant mutational signature in colorectal cancer genomes is C > T deamination (COSMIC Signature 1) and, in a small subgroup, mismatch repair signature (COSMIC signatures 6 and 44). Mutations in common colorectal cancer driver genes are often not consistent with those signatures. Here we perform whole-genome sequencing of normal colon crypts from cancer patients, matched to a previous multi-omic tumour dataset. We analyse normal crypts that were distant vs adjacent to the cancer. In contrast to healthy individuals, normal crypts of colon cancer patients have a high incidence of pks + (polyketide synthases) E.coli (Escherichia coli) mutational and indel signatures, and this is confirmed by metagenomics. These signatures are compatible with many clonal driver mutations detected in the corresponding cancer samples, including in chromatin modifier genes, supporting their role in early tumourigenesis. These results provide evidence that pks + E.coli is a potential driver of carcinogenesis in the human gut.